humanized anti-S100A9 antibodies (Inflammatorx)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namehumanized anti-S100A9 antibodies (Inflammatorx)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionS100 calcium binding protein A9 inhibitors

TargetsS100 calcium binding protein A9

Therapy Area/IndicationsNerve DegenerationInflammationAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesInflammatorx Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesInflammatorx Inc

Active IndicationsN/A

Inactive IndicationsNerve DegenerationInflammationAutoimmune Diseases

ATC CodeN/A